Key facts
- Notable investors include Huayi Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Xenta Biomedical Science Co., Ltd
- ·The full record, as it builds
Funding rounds
No funding rounds for Xenta Biomedical Science Co., Ltd are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Xenta Biomedical Science Co., Ltd
Manufacturer of diagnostic instruments and reagents intended to facilitate rapid and accurate detection of infectious diseases and other clinical conditions. The company offers advanced PCR instruments, antigen testing kits, and specialized reagents, enabling healthcare laboratories and clinical facilities to achieve precise, efficient, and reliable diagnostic outcomes.
- Sector
- Healthcare
- HQ
- Guangzhou, China
- Founded
- 2021
- Website
- xentabms.com/
- Ownership
- Privately Held (backing)
Xenta Biomedical Science Co., Ltd doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Xenta Biomedical Science Co., Ltd shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Xenta Biomedical Science Co., Ltd in its N-PORT filings yet. We sweep new filings monthly.